Kalii Chloridum/Glucosum B. Braun

Potassium chloride and glucose, the active ingredient in Kalii Chloridum/Glucosum B. Braun, is an electrolyte solution presented as an injection solution for intravenous use. It treats hypokalemia and provides fluid and electrolyte replacement in hospitalized patients. It is also employed in perioperative fluid management and to prevent hypoglycemia during intravenous therapy. The combination supplies potassium ions to correct low serum potassium levels while glucose offers an energy source and contributes to osmotic balance. It is manufactured under EU GMP standards for clinical use.

GNH USA supplies Kalii Chloridum/Glucosum B. Braun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Kalii Chloridum/Glucosum B. Braun is used to manage electrolyte and fluid disorders in clinical settings.

- Hypokalemia: restores serum potassium levels to prevent cardiac and muscular complications. - Fluid and electrolyte replacement: supplies potassium and glucose to correct deficits during dehydration or loss. - Perioperative fluid management: maintains electrolyte balance and provides energy during surgery. - Prevention of hypoglycemia: delivers glucose intravenously to avoid low blood sugar in patients unable to eat.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Mild hyperkalemia: slight elevation of serum potassium without symptoms. - Mild hyperglycemia: modest increase in blood glucose levels.

Serious or Rare Side Effects: - Severe hyperkalemia with cardiac arrhythmia: potentially life‑threatening heart rhythm disturbances. - Anaphylactic reaction: sudden severe allergic response requiring emergency treatment. - Severe hyperglycemia with ketoacidosis: dangerous rise in blood sugar leading to metabolic acidosis. - Electrolyte imbalance causing muscle weakness or cardiac issues: significant disturbances in potassium or other electrolytes.

Precautions should be observed when using this intravenous solution.

- Dose adjustment: adjust infusion rate in patients with renal impairment. - Cardiac monitoring: monitor ECG for arrhythmias during therapy. - Blood glucose monitoring: check glucose levels regularly. - Electrolyte monitoring: assess serum potassium before and during infusion. - Compatibility: ensure solution is compatible with other IV fluids before mixing. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions must be considered.

Major Interactions (Avoid): - ACE inhibitors: may increase potassium levels leading to hyperkalemia. - Potassium‑sparing diuretics: risk of severe hyperkalemia. - Insulin therapy: may cause rapid intracellular shift of potassium. - Sodium bicarbonate: can cause potassium shifts and affect serum levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate hyperkalemia. - Digitalis: increased risk of arrhythmia with elevated potassium. - IV glucose with insulin: monitor glucose levels closely to avoid hypoglycemia.